Flotrex Tablet, Chewable
NDC Package 59088-017-54
Package Information
Flotrex (multivitamins, sodium fluoride 0.25 mg) tablets is this prescription chewable tablet is indicated for the prevention and treatment of vitamin and fluoride deficiencies in patients at high risk for dental caries and inadequate dietary intake of essential vitamins. This formulation utilizes a tablet, chewable delivery system. Marketed by Puretek Corporation, this product is identified by NDC 59088-017.
Identification & Billing
Clinical Specifications
- .ALPHA.-TOCOPHEROL ACETATE, DL- 6.75 mg/1
- ASCORBIC ACID 24 mg/1
- CHOLECALCIFEROL 10 ug/1
- CYANOCOBALAMIN 4.5 ug/1
- FOLIC ACID 300 ug/1
- NIACINAMIDE 13.5 mg/1
- PYRIDOXINE HYDROCHLORIDE 1.05 mg/1
- RIBOFLAVIN 1.2 mg/1
- SODIUM ASCORBATE 36 mg/1
- SODIUM FLUORIDE .25 mg/1
- THIAMINE MONONITRATE 1.05 mg/1
- VITAMIN A 750 ug/1
- Analogs/Derivatives - [Chemical/Ingredient]
- Ascorbic Acid - [CS]
- Vitamin A - [CS]
- Vitamin A - [EPC] (Established Pharmacologic Class)
- Vitamin B 12 - [CS]
- Vitamin B 6 - [Chemical/Ingredient]
- Vitamin B12 - [EPC] (Established Pharmacologic Class)
- Vitamin B6 Analog - [EPC] (Established Pharmacologic Class)
- Vitamin C - [EPC] (Established Pharmacologic Class)
- Vitamin D - [CS]
- Vitamin D - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 59088 - Puretek Corporation
- 59088-017 - Flotrex
- 59088-017-54 - 30 TABLET, CHEWABLE in 1 BOTTLE, PLASTIC
- 59088-017 - Flotrex
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 59088-017-54 identifies a specific commercial package of 30 tablet, chewable in 1 bottle, plastic of Flotrex, a human prescription drug labeled by Puretek Corporation. This product is billed for "EA" each discreet unit and contains an estimated amount of 30 billable units per package. This tablet, chewable is formulated for oral use and contains .alpha.-tocopherol acetate, dl-; ascorbic acid; cholecalciferol; cyanocobalamin; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin; sodium ascorbate; sodium fluoride; thiamine mononitrate; vitamin a as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Puretek Corporation on March 19, 2025. The current certification is valid through December 31, 2026.
How is this Puretek Corporation product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 59088001754. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 30 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.